Since a significant percentage of AML shows consistently increased MN1 expression levels, this could represent a candidate marker suitable to discriminate between normal and leukemic hematopoiesis and useful to establish the presence, persistence or reappearance of leukemic clone. This evidence concerns the gene MN1 and acute myeloid leukemia.